en

PRODUCT DETAIL

Viekirax 12,5 mg/75 mg/50 mg filmom obalené tablety

Code 2709B
MA number EU/1/14/982/001
Product Form: tbl flm 56(4x14)x12,5 mg/75 mg/50 mg (blis.PVC/PE/PCTFE/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP ?
J05AP53 Ombitasvir, paritaprevir a ritonavir
Shelf life: 36
Container: blister PVC/PE/PCTFE/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.01.2015
SmPC + PL: European Medicines Agency's database
Dokument: DHCP Viekira a Exviera 4 1 2016.pdf  
Safety feature Yes
Data update: 27.09.2019
eu-flag.png sk-flag.png